AKAnders Riegels Knudsen

Anders Riegels Knudsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anders Riegels Knudsen has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Piperacillin concentrations in bile—a prospective observational study in ERCP patients

    by Louise L. Pontoppidan, Mats Bue, Helle Precht, Pelle Hanberg, Kim C. Houlind, Jan B. Pedersen, Anders R. Knudsen

    Surgical site infections complicate up to 30% of hepato-pancreato-biliary (HPB) procedures, with biliary obstruction potentially increasing this risk. Recent studies suggest prophylactic piperacillin/tazobactam (TZP) may offer superior protection compared to cephalosporins. Piperacillin concentrations must exceed the minimum inhibitory concentration (MIC) of key bacterial pathogens in the surgical field, commonly exhibiting MICs of 8 and 16 mg/L. The aim of the study was to evaluate piperacillin concentrations in plasma and bile over time relative to MIC targets (8–16 mg/L), and to evaluate the impact of biliary obstruction. Ninety-nine patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) received an intravenous dose of TZP (4/0.5 g), followed by simultaneously plasma and bile sampling at random intervals. In a post hoc analysis, the patients were stratified by bilirubin levels: non-obstructed (≤ 25 µmol/L) and obstructed (> 25 µmol/L). Piperacillin was quantified using ultra-high-performance liquid chromatography. In non-obstructed patients ( n = 77), biliary concentrations exceeded the MIC targets ≥ 245 min (peak 3,105 mg/L), while plasma levels remained above the MIC targets for 190 min (peak 431 mg/L). In the obstructed group ( n = 22), bile concentrations were inconsistent, with malignant obstruction associated with subtherapeutic levels. Plasma concentrations were similar between groups. Piperacillin provides sustained biliary concentrations above MIC targets. Malignant obstruction may compromise biliary drug exposure and warrants consideration of alternative dosing strategies. Clinical trial : The study qualified as a medical trial and was registered at the EU Clinical Trials Register with an EudraCT number: 2021-002629-95. The date of registration and approval for inclusion of patients was November 11th, 2022.

  • Open Access

    Surgical treatment of breast cancer liver metastases – A study from the Danish Liver Cancer Group

    by Lauge Hjorth Mikkelsen, Lasse Rehné Jensen, Andreas Bjerrum, Peter Nørgaard Larsen, Lucas Alexander Knøfler, Torsten Pless, Anders Riegels Knudsen, Susanne Dam Nielsen, Morten Ladekarl, Mogens Stender, et al.

  • Open Access

    Piperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs

    by Louise L. Pontoppidan, Mats Bue, Kim C. Houlind, Anders R. Knudsen, Jan B. Pedersen, Magnus A. Hvistendahl, Pelle Hanberg

    The antibiotic combination of piperacillin/tazobactam (TZP) is commonly utilized for preventing and treating infections in the biliary system, with piperacillin being the primary agent. Its effectiveness is closely related to the time with concentrations above the minimal inhibitory concentration ( T > MIC) of the bacteria involved. The most frequently encountered bacteria associated with biliary system infections present with clinical breakpoint MIC values of 8 and 16 µg/mL. This porcine study aimed to apply microdialysis to assess target site piperacillin T > MIC 8, 16, and 32 (4× MIC 8) µg/mL in the biliary system. In eight healthy pigs (Danish Landrace breed, weight 78–82 kg), five microdialysis catheters were placed for sampling of piperacillin concentrations in the liver, the wall of the gallbladder, the bile in the gallbladder, the wall of the common bile duct (CBD), and the bile in the CBD. A bolus of TZP 4/0.5 g was administered intravenously, and microdialysates and blood samples were collected during an 8 h period. Ultrahigh performance liquid chromatography (UHPLC) was used to quantify the piperacillin concentrations. The mean T > MIC (%T > MIC) varied from 345 to 446 min (77%–99%), 261–446 min (58%–99%), and 200–444 min (42%–99%) for the MIC targets of 8, 16, and 32 µg/mL, respectively. The pharmacokinetic parameters in the bile were found to be different compared to the remaining compartments with higher AUC 0–8h and C max values and longer T 1/2 . Piperacillin displayed prolonged T > MIC in bile compared to plasma and the target tissues of the biliary system, approaching 100% T > MIC for the MIC targets of 8, 16, and 32 µg/mL.


  • Open Access

    Technique efficacy and complications after ablation as first surgical intervention for hepatocellular carcinoma: A nationwide database study

    by Jeanett Klubien, Lucas Alexander Knøfler, Andreas Runge Poulsen, Peter Nørgaard Larsen, Torsten Pless, Anders Riegels Knudsen, Susanne Dam Nielsen, Hans-Christian Pommergaard


  • Open Access

    Chronic stress does not impair liver regeneration in rats

    by Kasper J. Andersen, Anders R. Knudsen, Ove Wiborg, Frank V. Mortensen


  • Open Access

    Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver

    by Lin Nanna Okholm Mφller, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, Jens Randel Nyengaard, Stephen Hamilton-Dutoit, Elise Marie Okholm Mφller, Pia Svendsen, Holger Jon Mφller, Sφren Kragh Moestrup, Jonas Heilskov Graversen, et al.

    The Pringle maneuver is a way to reduce blood loss during liver surgery. However, this may result in ischemia/reperfusion injury in the development of which Kupffer cells play a central role. Corticosteroids are known to have anti-inflammatory effects. Our aim was to investigate whether a conjugate of dexamethasone and antibody against the CD163 macrophage cell surface receptor could reduce ischemia/reperfusion injury in the rat liver. Thirty-six male Wistar rats were used for the experiments. Animals were randomly divided into four groups of eight receiving anti-CD163-dexamethasone, high dose dexamethasone, low dose dexamethasone or placebo intravenously 18 h before laparotomy with subsequent 60 min of liver ischemia. After reperfusion for 24 h the animals had their liver removed. Bloods were drawn 30 min and 24 h post ischemia induction. Liver cell apoptosis and necrosis were analyzed by stereological quantification. After 24 h' reperfusion, the fraction of cell in non-necrotic tissues exhibiting apoptotic profiles was significantly lower in the high dose dexamethasone (p = 0.03) and anti-CD163-dex (p = 0.03) groups compared with the low dose dexamethasone and placebo groups. There was no difference in necrotic cell volume between groups. After 30 min of reperfusion, levels of haptoglobin were significantly higher in the anti-CD163-dex and high dose dexamethasone groups. Alanine aminotransferase and alkaline phosphatase were significantly higher in the high dose dexamethasone group compared to controls after 24 h' reperfusion. We show that pharmacological preconditioning with anti-CD163-dex and high dose dexamethasone reduces the number of apoptotic cells following ischemia/reperfusion injury.


  • Quantitative histological assessment of hepatic ischemia-reperfusion injuries following ischemic pre- and post-conditioning in the rat liver

    by Anders R. Knudsen, Anne-Sofie Kannerup, Henning Grønbæk, Stephen H. Dutoit, Jens R. Nyengaard, Peter Funch-Jensen, Frank V. Mortensen


  • Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion

    by Anders Riegels Knudsen, Anne-Sofie Kannerup, Rune Dich, Peter Funch-Jensen, Henning Grønbæk, Mogens Kruhøffer, Frank Viborg Mortensen

    Ischemic pre (IPC)- and postconditioning (IPO) protect the liver against ischemia/reperfusion injuries (IRI). Conditioning involves several different trigger factors, mediators, and effectors, many of which are affected during the early phase of reperfusion, ultimately resulting in decreased liver injuries. The aim of the present study was to investigate the genomic response induced by IPC and IPO in ischemia/reperfusion-damaged rat liver biopsies. Forty-eight male Wistar rats were divided into five groups: sham ( n = 8), IRI ( n = 10), IPC ( n = 10), IPO ( n = 10), and IPC + IPO ( n = 10). The rat livers were subjected to 30 min of ischemia. Liver biopsies and blood samples were taken after 30 min of reperfusion. The biopsies were analyzed using cDNA microarrays with validation by quantitative RT-PCR. The significance analysis of microarray was used to identify genes with changed expression levels. A comparison analysis of the intervention groups showed a highly increased number of genes, with significantly different expression in the conditioned groups compared with the IRI group. A total of 172 genes were identified as the most highly affected, and these genes showed similar patterns with regard to the up- and downregulated expression levels within the conditioned groups. Pathway analysis of the 172 genes identified four networks that were involved in increased gene expression, cellular growth, and proliferation. In conclusion, the present study demonstrated that IPC, IPO, and IPC + IPO had pronounced effects on the expression levels of a large number of genes during early reperfusion. IPC, IPO, and IPC + IPO seem to mediate their protective effects by regulating the same genes and genetic networks. These identified networks are known to be involved in maintaining cellular homeostasis.


  • Open Access

    Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver

    by Anders R Knudsen, Anne-Sofie Kannerup, Henning Grønbæk, Kasper J Andersen, Peter Funch-Jensen, Jan Frystyk, Allan Flyvbjerg, Frank V Mortensen

    Ischemic pre- and postconditioning protects the liver against ischemia/reperfusion injuries. The aim of the present study was to examine how ischemic pre- and postconditioning affects gene expression of hypoxia inducible factor 1α (HIF-1α), vascular endothelial growth factor A (VEGF-A) and transforming growth factor β (TGF-β) in liver tissue.


  • Expression of genes involved in rat liver angiogenesis after ischaemia and reperfusion: effects of ischaemic pre- and post-conditioning

    by Anders R. Knudsen, Anne-Sofie Kannerup, Rune Dich, Mogens Kruhøffer, Peter Funch-Jensen, Henning Grønbæk, Frank V. Mortensen